NASDAQ · Medical - Devices

TMCI (TMCI) Stock

$4.08 +2.00% NASDAQ: TMCI Healthcare

Valuation

MetricValue
Price$4.08
Market Cap$264.68M
P/E Ratio-2.92
P/B Ratio2.03
P/S Ratio0.88
EPS (TTM)$-0.93
52-Week High$7.78
52-Week Low$1.17
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-67.82%
ROA-30.89%
ROCE-61.36%
Gross Margin-25.35%
Operating Margin-25.35%
Net Margin-29.44%
Debt/Equity0.18
Current Ratio4.26

Annual Financials (USD)

Metric20212022202320242025
Revenue$94.0M$142.0M$187.0M$209.0M$213.0M
Operating Profit$-17.0M$-35.0M$-51.0M$-56.0M$-54.0M
Net Profit$-21.0M$-43.0M$-50.0M$-56.0M$-59.0M
EPS$-0.38$-0.77$-0.81$-0.90$-0.93
Op Margin-17.5%-24.6%-27.5%-26.6%-25.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$141.0M$159.0M$252.0M$217.0M$191.0M
Total Liabilities$48.0M$98.0M$114.0M$104.0M$103.0M
Cash$106.0M$19.0M$13.0M$11.0M$11.0M
Borrowings$29.0M$69.0M$70.0M$70.0M$14.0M

Latest News

Truist Securities Adjusts Price Target on Treace Medical Concepts to $4 From $2, Maintains Hold Rating MT Newswires · Jul 16, 2026 Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System GlobeNewswire · Jun 18, 2026 Sidoti Events, LLC's June Small-Cap Virtual Conference ACCESS Newswire · Jun 16, 2026 Treace to Present at the Sidoti Small Cap Conference GlobeNewswire · Jun 11, 2026 June 2026's Top Penny Stocks To Watch Simply Wall St. · Jun 11, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-17.0M$-31.0M$-35.0M$-37.0M$-16.0M
Investing Cash Flow$-5.0M$-91.0M$-93.0M$24.0M$0
Financing Cash Flow$0$-1.0M$0$0$-1.0M
Net Cash Flow$88.0M$-86.0M$-6.0M$-2.0M$-1.0M
Free Cash Flow$-20.0M$-45.0M$-46.0M$-49.0M$-29.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-14.20%
Quick Ratio2.53
Interest Coverage-10.80
Return 1Y-33.39%
Return 3Y-81.72%
Return 5Y-83.72%

Ownership

Insiders Held25.35%
Institutions Held56.95%
Institutions Float Held76.28%
Institutional HolderSharesReport Date
Armistice Capital, LLC6,364,0002026-03-31
Gagnon Securities, LLC5,201,8862026-03-31
Blackrock Inc.3,340,0232026-03-31
Bank of America Corporation3,214,2932026-03-31
Vanguard Capital Management LLC1,461,5072026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BVS $13.12 -0.68% 20.85 $888.85M 0.00%
CBLL $18.81 +3.07% -11.62 $713.70M 0.00%
EHABEnhabit Inc $13.80 +0.07% -153.33 $706.91M 0.00%
EOLS $6.03 -3.05% -9.25 $397.10M 0.00%
KIDS $22.77 -0.26% -10.79 $584.85M 0.00%

About TMCI

TMCI is led by CEO John T. Treace, employs 477 people, headquartered in US, publicly traded since 2021.

TMCI stock trades at $4.08 with a market capitalization of $264.68M. The stock is valued at a price-to-earnings (P/E) ratio of -2.92, price-to-book of 2.03, price-to-sales of 0.88. Over the past 52 weeks the stock has ranged between $1.17 and $7.78, and currently trades 47.6% below its 52-week high.

On profitability, TMCI generates a return on equity (ROE) of -67.82%, return on capital employed of -61.36%, an operating margin of -25.35%, a net profit margin of -29.44%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides